Erica Leifheit-Limson, Coauthors and PhD from Yale College of Public Health and School of Medicine, and Yale-New Haven Hospital , St. Luke's Mid America Heart Institute and University of Missouri-Kansas City , and Emory University Rollins School of Public Health and the School of Medicine report the analysis results in the article Prevalence of Traditional Cardiac Risk Elements and Secondary Prevention Among Sufferers Hospitalized for Acute Myocardial Infarction : Variation by Age, Sex, and Race. These results indicate missed possibilities for both avoidance and management of cardiac risk elements, particularly for women and minority patients, says Susan G. Kornstein, MD, Editor-in-Chief of Journal of Ladies's Wellness, Executive Director of the Virginia Commonwealth University Institute for Ladies's Wellness, Richmond, VA, and President of the Academy of Ladies's Health..ALDA Pharmaceuticals begins patent applications ALDA Pharmaceuticals has filed national patent applications in the United States, Canada and Singapore for the formulation and production of Viralex. Passing the worldwide review can be an important step in the process and allows the company to file patent applications in those countries that have attractive marketplace potential. Dr. Patent protection signifies our technology is sound and is completely essential to attract joint venture companions and licensees for many of our planned items. The surveyed rheumatologists are excited to have a fresh biologic agent that provides a unique mechanism of actions and every one of the respondents intends to use Actemra within their practice although the timeframe for adoption will vary.